Advertisement

Approach to Diagnosis of Secondary Cardiomyopathies With Left Ventricular Hypertrophy

      Left ventricular hypertrophy (LVH) is often encountered cardiac disorder with heterogeneous clinical presentation and course. Although unexplained LVH is the hallmark of hypertrophic cardiomyopathy, differential diagnosis of secondary cardiomyopathies with LVH has been needed. Because, disease-oriented treatments have made progress. For example, the enzyme replacement therapy for Anderson-Fabry disease promises the modification of natural course of disease. In the first half of this presentation, we will overview the clinical significance of diagnostic procedures such as medical history, physical examination, laboratory data, electrocardiography, echocardiography, cardiac magnetic resonance, and cardiac catheterization including endomyocardial biopsy, in secondary cardiomyopathies with LVH. Particularly, we have been reported the clinical utility of biomarkers in differential diagnosis and risk assessment in cardiomyopathies with LVH from the regional cardiomyopathy registry named Kochi Cardiomyopathy Network. In the second half of this presentation, we will suggest the new strategy of differential diagnosis of secondary cardiomyopathies with LVH.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect